RT Journal Article
SR Electronic
T1 OBESITY MAY HAMPER SARS-CoV-2 VACCINE IMMUNOGENICITY
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.02.24.21251664
DO 10.1101/2021.02.24.21251664
A1 Pellini, Raul
A1 Venuti, Aldo
A1 Pimpinelli, Fulvia
A1 Abril, Elva
A1 Blandino, Giovanni
A1 Campo, Flaminia
A1 Conti, Laura
A1 De Virgilio, Armando
A1 De Marco, Federico
A1 Di Domenico, Enea Gino
A1 Di Bella, Ornella
A1 Di Martino, Simona
A1 Ensoli, Fabrizio
A1 Giannarelli, Diana
A1 Mandoj, Chiara
A1 Manciocco, Valentina
A1 Marchesi, Paolo
A1 Mazzola, Francesco
A1 Moretto, Silvia
A1 Petruzzi, Gerardo
A1 Petrone, Fabrizio
A1 Pichi, Barbara
A1 Pontone, Martina
A1 Zocchi, Jacopo
A1 Vidiri, Antonello
A1 Vujovic, Branka
A1 Piaggio, Giulia
A1 Morrone, Aldo
A1 Ciliberto, Gennaro
YR 2021
UL http://medrxiv.org/content/early/2021/02/26/2021.02.24.21251664.abstract
AB Background The first goal of the study was to analyse the antibody titre 7 days after the second dose of BNT162b2 vaccine in a group of 248 healthcare workers (HCW). The second goal was to analyse how the antibody titre changes in correlation with age, gender and BMI.Methods Participants were assigned to receive the priming dose at baseline and booster dose at day 21. Blood and nasopharyngeal swabs were collected at baseline and 7 days after second dose of vaccine.Findings 248 HWCs were analysed, 158 women (63.7%) and 90 men (36.3%). After the second dose of BNT162b2 vaccine, 99.5% of participants developed a humoral immune response.The geometric mean concentration of antibodies among the vaccinated subjects after booster dose (285.9 AU/mL 95% CI: 249.5-327.7); was higher than that of human convalescent sera (39.4 AU/mL, 95% CI: 33.1-46.9), with p<0.0001. The antibody titre was found to be higher in young and female participants. A strong correlation of BMI classes with antibody titres was noticed: humoral response was more efficient in the group with under- and normal-weight vs the group with pre- and obesity participants (p<0.0001 at T1).Interpretation These findings imply that females, lean and young people have an increased capacity to mount humoral immune responses compared to males, overweight and the older population. Although further studies are needed, this data may have important implications for the development of vaccination strategies for COVID-19, particularly in obese people.Funding NoneCompeting Interest StatementThe authors have declared no competing interest.Clinical TrialISRCTN55371988Funding StatementNo funding supported in the workAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol complied with the tenets of the Helsinki declaration . The study was approved by COMITATO ETICO CENTRALE I.R.C.C.S. LAZIO Sezione IRCCS I.F.O. Fondazione G.B. Bietti. The report number is 01, date 26.01.2021, protocol RS1463/21.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesI confirm the availability of all data referred to in the manuscript